Recursion Pharmaceuticals, Inc. (RXRX)

3.42 -0.30 (-8.06%) USD  |  NASDAQ  |  Feb 20, 16:00
3.37 -0.05 (-1.46%) Pre-Market: 09:14
More

Recursion Pharmaceuticals Sell Recommendations

Sell Recommendations Chart

View Sell Recommendations for RXRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Sell Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Sell Recommendations Range, Past 5 Years

View Sell Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Sell Recommendations Benchmarks

View Sell Recommendations Benchmarks
Start Trial
Hims & Hers Health, Inc. Upgrade
Intellia Therapeutics, Inc. Upgrade
XOMA Royalty Corp. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade
Tango Therapeutics, Inc. Upgrade